Takeda Stresses Orexin Commitment Despite Setback

Big Share Buyback As Q2 Reported

 
• By Ian Haydock
  
narcolepsy
Takeda looks to hold up orexin franchise after recent trial halt • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business